Jennifer Straumins Sells 100,000 Shares of Calumet Specialty Products Partners, L.P. (NASDAQ:CLMT) Stock

Calumet Specialty Products Partners, L.P. (NASDAQ:CLMT - Get Free Report) Director Jennifer Straumins sold 100,000 shares of the stock in a transaction dated Thursday, June 5th. The shares were sold at an average price of $13.17, for a total value of $1,317,000.00. Following the completion of the transaction, the director now directly owns 1,084,589 shares in the company, valued at $14,284,037.13. The trade was a 8.44% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this link.

Calumet Specialty Products Partners Stock Performance

NASDAQ CLMT traded up $0.23 during trading hours on Friday, reaching $13.44. 463,284 shares of the company's stock were exchanged, compared to its average volume of 933,072. The company has a market capitalization of $1.16 billion, a price-to-earnings ratio of -4.87 and a beta of 0.89. The company's 50-day moving average is $11.75 and its two-hundred day moving average is $15.63. Calumet Specialty Products Partners, L.P. has a one year low of $7.68 and a one year high of $25.29.

Calumet Specialty Products Partners (NASDAQ:CLMT - Get Free Report) last issued its quarterly earnings data on Friday, May 9th. The oil and gas company reported ($1.03) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.41) by ($0.62). The firm had revenue of $993.90 million for the quarter, compared to the consensus estimate of $899.62 million. During the same period last year, the company earned ($0.51) earnings per share. The firm's quarterly revenue was down 1.2% compared to the same quarter last year. Research analysts predict that Calumet Specialty Products Partners, L.P. will post -3.02 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

A number of analysts have recently commented on CLMT shares. HC Wainwright reaffirmed a "buy" rating and issued a $33.00 price target on shares of Calumet Specialty Products Partners in a research note on Monday, March 3rd. TD Cowen cut shares of Calumet Specialty Products Partners from a "buy" rating to a "hold" rating and decreased their price objective for the company from $26.00 to $16.00 in a report on Tuesday, March 4th. The Goldman Sachs Group cut their target price on shares of Calumet Specialty Products Partners from $16.00 to $14.00 and set a "buy" rating on the stock in a report on Wednesday, April 30th. UBS Group raised shares of Calumet Specialty Products Partners from a "sell" rating to a "neutral" rating and decreased their price target for the company from $15.00 to $12.00 in a report on Monday, March 17th. Finally, Bank of America began coverage on shares of Calumet Specialty Products Partners in a research report on Tuesday, May 13th. They issued a "buy" rating and a $15.00 price objective for the company. One research analyst has rated the stock with a sell rating, two have assigned a hold rating and four have given a buy rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of "Hold" and a consensus price target of $18.50.

Calumet Specialty Products Partners Company Profile

Calumet, Inc engages in the manufacturing, formulating, and marketing of a diversified slate of specialty branded products and renewable fuels to customers across a broad range of consumer-facing and industrial markets. It operates through the following segments: Specialty Products & Solutions, Performance Brands, Montana/Renewables, and Corporate.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.